We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
GATX Corp
GATX
$6.27B
| $14.7M | 0.01% |
133,762
-4,658
| -3% | -$508K |
|
1227
Enovis
ENOV
$1.53B
| $14.7M | 0.01% |
274,808
-109,661
| -29% | -$6.35M |
|
1228
Viridian Therapeutics
VRDN
$2.67B
| $14.7M | 0.01% |
577,627
+256,161
| +80% | +$8.21M |
|
1229
MannKind Corp
MNKD
$1.32B
| $14.7M | 0.01% |
3,574,020
+2,784,563
| +353% | +$13.4M |
|
|
ALTR
1230
DELISTED
Altair Engineering Inc
ALTR
| $14.6M | 0.01% |
201,790
+8,659
| +4% | +$512K |
|
1231
United Natural Foods
UNFI
$2.85B
| $14.5M | 0.01% |
551,417
-14,674
| -3% | -$535K |
|
1232
Array Technologies
ARRY
$855M
| $14.5M | 0.01% |
664,039
-146,236
| -18% | -$2.99M |
|
|
LTHM
1233
DELISTED
Livent Corporation
LTHM
| $14.5M | 0.01% |
667,828
+31,359
| +5% | +$725K |
|
|
AZEK
1234
DELISTED
The AZEK Co
AZEK
| $14.5M | 0.01% |
615,432
+208,329
| +51% | +$4.93M |
|
1235
Zillow
ZG
$7.63B
| $14.5M | 0.01% |
331,463
+85,442
| +35% | +$3.56M |
|
|
CWEN.A
1236
DELISTED
Clearway Energy Class A
CWEN.A
| $14.5M | 0.01% |
482,286
-85,862
| -15% | -$2.62M |
|
|
VRTV
1237
DELISTED
VERITIV CORPORATION
VRTV
| $14.5M | 0.01% |
107,100
+9,066
| +9% | +$1.16M |
|
1238
James River Group Holdings
JRVR
$217M
| $14.4M | 0.01% |
699,498
+82,634
| +13% | +$1.82M |
|
1239
First Commonwealth Financial
FCF
$2.17B
| $14.4M | 0.01% |
1,159,940
+633,276
| +120% | +$9.13M |
|
1240
Ralph Lauren
RL
$23.6B
| $14.4M | 0.01% |
123,185
+28,371
| +30% | +$3.35M |
|
1241
StepStone Group
STEP
$3.82B
| $14.4M | 0.01% |
591,739
+202,272
| +52% | +$5.53M |
|
1242
Valaris
VAL
$5.47B
| $14.4M | 0.01% |
215,746
-114,349
| -35% | -$7.97M |
|
1243
Gentex
GNTX
$5.07B
| $14.3M | 0.01% |
511,355
-4,389
| -0.9% | -$124K |
|
1244
Clean Harbors
CLH
$16.3B
| $14.3M | 0.01% |
100,497
-40,666
| -29% | -$5.3M |
|
1245
10x Genomics
TXG
$6.61B
| $14.3M | 0.01% |
256,636
+37,298
| +17% | +$1.74M |
|
1246
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $14.3M | 0.01% |
187,609
+34,817
| +23% | +$2.89M |
|
|
EQC
1247
DELISTED
Equity Commonwealth
EQC
| $14.3M | 0.01% |
690,283
+213,959
| +45% | +$4.96M |
|
1248
RLI Corp
RLI
$5.89B
| $14.3M | 0.01% |
214,634
-2,452
| -1% | -$163K |
|
1249
OSI Systems
OSIS
$3.89B
| $14.2M | 0.01% |
139,146
-1,790
| -1% | -$166K |
|
1250
Haemonetics
HAE
$4B
| $14.2M | 0.01% |
171,919
-23,092
| -12% | -$1.87M |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.